Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001432966 | SCV001635749 | likely benign | not provided | 2022-11-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004945138 | SCV005444623 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-07-30 | criteria provided, single submitter | clinical testing | The c.2386C>A variant (also known as p.R796R), located in coding exon 17 of the MSH3 gene, results from a C to A substitution at nucleotide position 2386. This nucleotide substitution does not change the arginine at codon 796. This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration may weaken the native splice donor site. Based on the available evidence, the clinical significance of this variant remains unclear. |